The JDRF Center of Excellence in New England will accelerate beta cell replacement therapy
Harvard Stem Cell Institute (HSCI) co-director Douglas Melton, Ph.D., will lead a new multi-institutional center funded by JDRF to advance type 1 diabetes research. The JDRF Center of Excellence in New England will focus on the transplantation of beta cells, the insulin-producing cells of the pancreas that are attacked by the immune system during type 1 diabetes.
The center is also led by JDRF scientific staff leader Esther Latres, Ph.D. Other collaborators include...
Read more about HSCI co-director leads multi-institutional center to advance type 1 diabetes research
